Yüklüyor......
Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women
INTRODUCTION: In settings where HIV is prevalent in heterosexual population, pregnancy and postpartum breastfeeding periods can be associated with substantial HIV acquisition risk. Pre-exposure prophylaxis (PrEP) with daily oral tenofovir disoproxil fumarate (TDF)/emtricitabine is an attractive HIV...
Kaydedildi:
| Yayımlandı: | Expert Opin Drug Saf |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5581312/ https://ncbi.nlm.nih.gov/pubmed/28571500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2017.1338271 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|